Larson Financial Group’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$121 Hold
42
﹤0.01% 3640
2026
Q1
$82 Hold
42
﹤0.01% 3524
2025
Q4
$114 Hold
42
﹤0.01% 3328
2025
Q3
$178 Sell
42
-2,074
-98% -$9.12K ﹤0.01% 3275
2025
Q2
$10.5K Buy
2,116
+38
+2% +$165 ﹤0.01% 1786
2025
Q1
$9.16K Buy
2,078
+2,036
+4,848% +$9.56K ﹤0.01% 1672
2024
Q4
$195 Hold
42
﹤0.01% 2448
2024
Q3
$291 Hold
42
﹤0.01% 2258
2024
Q2
$328 Hold
42
﹤0.01% 1940
2024
Q1
$298 Hold
42
﹤0.01% 1608
2023
Q4
$281 Hold
42
﹤0.01% 1628
2023
Q3
$236 Hold
42
﹤0.01% 1627
2023
Q2
$232 Buy
+42
New +$226 ﹤0.01% 1488

Other funds holding GDRX

Larson Financial Group's GDRX Position: Q2 2026 in Review

Larson Financial Group held its GoodRx Holdings (GDRX) position steady in Q2 2026 at 42 shares worth $121. The position accounts for ﹤0.01% of the portfolio, ranked #3640.

Larson Financial Group first reported a position in GDRX in Q2 2023 and has held it in 13 quarters since. The position peaked at $10.5K in Q2 2025. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Larson Financial Group held 42 shares of GoodRx Holdings worth $121 as of Q2 2026.
  • Larson Financial Group left its GoodRx Holdings share count unchanged in Q2 2026.
  • GoodRx Holdings made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3640 holding.
  • Larson Financial Group first reported a position in GoodRx Holdings in Q2 2023 and has held it in 13 quarters since.
  • Larson Financial Group's GoodRx Holdings position peaked at $10.5K in Q2 2025.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.